From Medscape Allergy & Immunology

Coverage from the

European Society for Immunodeficiencies (ESID) 2016 Biennial Meeting

September 21 - 24, 2016; Barcelona, Spain

September 21 - 24, 2016 Barcelona, Spain

ESID Newborn Screening for SCID Making Gains Globally Mandatory screening of newborns for severe combined immunodeficiency disease (SCID) could lead to better care and the identification of more cases, according to proponents.
Medscape Medical News, September 26, 2016
ESID Genetic Test Results Spur Ethical Dilemmas A panel of experts discuss the many ethical implications of genetic testing and the moral responsibility of doctors and patients to deal with the information.
Medscape Medical News, September 23, 2016
ESID Immunodeficiency May Be Complicated by Asthma, Allergies Testing patients with common variable immunodeficiency for asthma and allergies can lead to better disease management after positive results, new research suggests.
Medscape Medical News, September 22, 2016

Conference News

ESID Newborn Screening for SCID Making Gains Globally
Medscape Medical News, September 26, 2016
ESID Genetic Test Results Spur Ethical Dilemmas
Medscape Medical News, September 23, 2016
ESID Factor Lifestyle Into Immunodeficiency Treatment Choice
Medscape Medical News, September 23, 2016

ESID Immunodeficiency May Be Complicated by Asthma, Allergies
Medscape Medical News, September 22, 2016
ESID Screening, Genetics Hot Topics at Immunodeficiency Meeting
Medscape Medical News, September 19, 2016

Popular Immunodeficiency News

Multiple Autoimmune Diseases Share Same Genetic Risk Factors A study that identified common gene sites across 10 pediatric-onset autoimmune diseases may reveal new treatment targets.
Medscape Medical News, Sep 4, 2015
SCID Prevalence Double Previous Estimates New findings support the view that severe combined immunodeficiency has previously been underdiagnosed in infants with fatal infections.
Medscape Medical News, Aug 19, 2014
Real-World PrEP Use Virtually Eliminates HIV Transmission The effectiveness of pre-exposure prophylaxis (PrEP) is surpassing expectations, and researchers are seeing stronger HIV prevention rates than were first reported in clinical trials.
Medscape Medical News, Jul 21, 2016

Medscape Allergy & Immunology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Related Resource

Immunization News & Perspectives